Neurology Devices are specialized surgical devices used for the treatment of diseases or conditions of Central Nervous System (CNS) and spine. Intracranial Pressure (ICP) monitoring devices are medical devices used to measure pressure within the skull in patients with neurological conditions that can cause increased intracranial pressure. The External Ventricular Drainage (EVD) and Microtransducer devices are covered under this market. GlobalData uses proprietary data and analytics to provide a comprehensive report on the icp monitoring devices devices market, including market shares of different players within Japan. Buy the latest report here.
Smarter leaders trust GlobalData
In 2023, GlobalData’s Market Model methodology determined that the leading player in the icp monitoring devices market in Japan was Integra LifeSciences followed by Medtronic, Raumedic and Sophysa.
The EVD is a kit along with a small tube surgically inserted that allows the temporary drainage of Cerebrospinal Fluid (CSF) from the ventricles of the brain, which helps to relieve intracranial pressure. Microtransducer devices are primarily used for measuring Intracranial Pressure.
The value of the icp monitoring devices devices market within Japan was expected to be over $10m in 2023.
For the latest complete market share analysis of icp monitoring devices device market in Japan, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
